Nothing Special   »   [go: up one dir, main page]

TNSN91049A1 - SUBSTITUTED BENZIMIDAZOLES, PROCESSES FOR THEIR PREPARATION, AND THEIR PHARMACEUTICAL USE - Google Patents

SUBSTITUTED BENZIMIDAZOLES, PROCESSES FOR THEIR PREPARATION, AND THEIR PHARMACEUTICAL USE

Info

Publication number
TNSN91049A1
TNSN91049A1 TNTNSN91049A TNSN91049A TNSN91049A1 TN SN91049 A1 TNSN91049 A1 TN SN91049A1 TN TNSN91049 A TNTNSN91049 A TN TNSN91049A TN SN91049 A TNSN91049 A TN SN91049A TN SN91049 A1 TNSN91049 A1 TN SN91049A1
Authority
TN
Tunisia
Prior art keywords
carbon atoms
processes
preparation
pharmaceutical use
atoms
Prior art date
Application number
TNTNSN91049A
Other languages
French (fr)
Inventor
Elof Brandstrom Arne
Lennart Lindberg Per
Elisabeth Sunden Gunnel
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of TNSN91049A1 publication Critical patent/TNSN91049A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

LES COMPOSES NOUVEAU AYANT LA FORMULE I OU R1 ET R2, QUI SONT DIFFERENTS, SONT CHACUN H, ALKYLE CONTENANT 1 A 4 ATOMES DE CARBONE OU - C(O)-R6 ; PARMI R1 ET R2 L'UN EST TOUJOURS SELECTIONNE A PARTIR DU GROUPE -C (O)-R6 ; DANS LEQUEL R6 EST ALKYLE CONTENANT 1 A 4 ATOMES DE CARBONE OU ALKOXY CONTENANT 1 A 4 ATOMES DE CARBONE, R3 EST LE GROUPE - CH2OCOOR7, OU R7 EST ALKYLE CONTENANT 1 A 6 ATOMES DE CARBONE OU BENZYLE ; R4 ET R5 SONT LES MEMES OU DIFFERENTS ET PEUVENT ETRE OCH3. FORMENT ENSEMBLE AVEC LES ATOMES D'OXYGENE ADJACENTS FIXES AU NOYAU PYRIDINE ET AVEC LES ATOMES DE CARBONE DU NOYAU PYRIDINE UN NOYAU, DANS LEQUEL LA PARTIE CONSTITUEE PAR R4 ET R5 EST -CH2CH2-CH2, -CH2CH2- OU - CH2-, AINSI QUE DES COMPOSITIONS PHARMACEUTIQUES CONTENANT LES DITS COMPOSES COMME INGREDIENTS ACTIFS, ET L'EMPLOI DE CES COMPOSES EN MEDECINETHE NEW COMPOUNDS WITH THE FORMULA I OR R1 AND R2, WHICH ARE DIFFERENT, ARE EACH H, ALKYL CONTAINING 1 TO 4 CARBON ATOMS OR - C (O) -R6; AMONG R1 AND R2 ONE IS ALWAYS SELECTED FROM THE GROUP -C (O) -R6; IN WHICH R6 IS ALKYL CONTAINING 1 TO 4 CARBON ATOMS OR ALKOXY CONTAINING 1 TO 4 CARBON ATOMS, R3 IS THE GROUP - CH2OCOOR7, OR R7 IS ALKYL CONTAINING 1 TO 6 CARBON OR BENZYL ATOMS; R4 AND R5 ARE THE SAME OR DIFFERENT AND MAY BE OCH3. FORMED TOGETHER WITH THE ATOMS OF OXYGEN ADJACENT FIXED TO THE PYRIDINE CORE AND WITH THE CARBON ATOMS OF THE PYRIDINE CORE A CORE, IN WHICH THE PART CONSISTING OF R4 AND R5 IS -CH2CH2-CH2, -CH2CH2- OR - CH2-, PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS AS ACTIVE INGREDIENTS, AND THE USE OF SUCH COMPOUNDS IN MEDICINE

TNTNSN91049A 1990-06-20 1991-06-19 SUBSTITUTED BENZIMIDAZOLES, PROCESSES FOR THEIR PREPARATION, AND THEIR PHARMACEUTICAL USE TNSN91049A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9002206A SE9002206D0 (en) 1990-06-20 1990-06-20 NEW COMPOUNDS

Publications (1)

Publication Number Publication Date
TNSN91049A1 true TNSN91049A1 (en) 1992-10-25

Family

ID=20379831

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN91049A TNSN91049A1 (en) 1990-06-20 1991-06-19 SUBSTITUTED BENZIMIDAZOLES, PROCESSES FOR THEIR PREPARATION, AND THEIR PHARMACEUTICAL USE

Country Status (27)

Country Link
EP (1) EP0535081A1 (en)
JP (1) JPH05507713A (en)
CN (1) CN1058212A (en)
AP (1) AP215A (en)
AU (1) AU649453B2 (en)
BG (1) BG97200A (en)
CA (1) CA2083714A1 (en)
CZ (1) CZ279772B6 (en)
FI (1) FI925766A (en)
HU (1) HUT62881A (en)
IE (1) IE912025A1 (en)
IL (1) IL98470A0 (en)
IS (1) IS3721A7 (en)
LT (2) LT3977B (en)
LV (1) LV10953A (en)
MA (1) MA22199A1 (en)
NO (1) NO924775D0 (en)
NZ (1) NZ238546A (en)
OA (1) OA09682A (en)
PT (1) PT98035A (en)
RO (1) RO110493B1 (en)
SE (1) SE9002206D0 (en)
TN (1) TNSN91049A1 (en)
TW (1) TW216418B (en)
WO (1) WO1991019711A1 (en)
YU (1) YU104191A (en)
ZA (2) ZA914296B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002043D0 (en) * 1990-06-07 1990-06-07 Astra Ab IMPROVED METHOD FOR SYNTHESIS
SE9103776D0 (en) * 1991-12-19 1991-12-19 Astra Ab NEW COMPOUNDS
IS4232A (en) * 1993-12-06 1995-06-07 Astra Aktiebolag Substituted benzimidazole, its methods of manufacture and pharmacological use
SE9500422D0 (en) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
SE9500478D0 (en) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
SE9600070D0 (en) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
MXPA02008232A (en) 2000-02-24 2004-04-05 Kopran Res Lab Ltd Orally administrable acid stable anti ulcer benzimidazole derivatives.
SE0101379D0 (en) 2001-04-18 2001-04-18 Diabact Ab Composition that inhibits gastric acid secretion
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
IL164222A0 (en) 2002-04-09 2005-12-18 Flamel Tech Sa Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
SE0203065D0 (en) 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
AU2004314693B2 (en) 2003-09-26 2011-04-07 Alza Corporation Drug coating providing high drug loading and methods for providing the same
TW200606163A (en) 2004-04-22 2006-02-16 Eisai Co Ltd Imidazopyridine compound
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US20070015782A1 (en) * 2005-04-15 2007-01-18 Eisai Co., Ltd. Benzimidazole compound
US9040564B2 (en) 2005-04-28 2015-05-26 Eisai R&D Management Co., Ltd. Stabilized composition
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
WO2007122686A1 (en) * 2006-04-14 2007-11-01 Eisai R & D Management Co., Ltd. Benzimidazole compounds
AU2007278986B2 (en) 2006-07-25 2010-09-16 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion using derivatives of small dicarboxylic acids in combination with PPI
JP5492417B2 (en) * 2006-10-13 2014-05-14 エーザイ・アール・アンド・ディー・マネジメント株式会社 Benzimidazole compound having gastric acid secretion inhibitory action
EA201100313A1 (en) 2008-09-09 2011-10-31 Астразенека Аб METHOD OF DELIVERY OF THE PHARMACEUTICAL COMPOSITION TO THE PATIENT NEEDING THIS
SG176724A1 (en) 2009-06-25 2012-01-30 Astrazeneca Ab Method for treating a patient at risk for developing an nsaid-associated ulcer
WO2011080501A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080500A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080502A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
EP2601947A1 (en) 2011-12-05 2013-06-12 Abo Bakr Mohammed Ali Al-Mehdar Fixed-dose combination for treatment of helicobacter pylori associated diseases
WO2013101897A2 (en) 2011-12-28 2013-07-04 Pozen Inc. Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
CN110234635B (en) * 2016-09-14 2023-03-10 宇凤·简·曾 Novel substituted benzimidazole derivatives as D-amino oxidase (DAAO) inhibitors

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE418966B (en) 1974-02-18 1981-07-06 Haessle Ab ANALOGY PROCEDURE FOR THE PREPARATION OF COMPOUNDS WITH Gastric Acid Secretion Inhibitory Effects
SE416649B (en) 1974-05-16 1981-01-26 Haessle Ab PROCEDURE FOR THE PREPARATION OF SUBSTANCES WHICH PREVENT Gastric acid secretion
IN148930B (en) 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (en) 1978-04-14 1979-10-15 Haessle Ab Gastric acid secretion
US4359465A (en) 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (en) 1980-08-21 1984-07-13 Hoffmann La Roche IMIDAZOLE DERIVATIVES.
SE8300736D0 (en) 1983-02-11 1983-02-11 Haessle Ab NOVEL PHARMACOLOGICALLY ACTIVE COMPOUNDS
SE8301182D0 (en) 1983-03-04 1983-03-04 Haessle Ab NOVEL COMPOUNDS
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US4738975A (en) 1985-07-02 1988-04-19 Takeda Chemical Industries, Ltd. Pyridine derivatives, and use as anti-ulcer agents
SE8505112D0 (en) * 1985-10-29 1985-10-29 Haessle Ab NOVEL PHARMACOLOGICAL COMPOUNDS
NZ234564A (en) 1986-11-21 1991-04-26 Haessle Ab 1-substituted benzimidazoles and pharmaceutical compositions
DE3722810A1 (en) * 1987-07-10 1989-01-19 Hoechst Ag SUBSTITUTED BENZIMIDAZOLES, METHOD FOR THE PRODUCTION THEREOF, THE PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THE USE THEREOF
JPH02501930A (en) * 1987-10-30 1990-06-28 アクチエボラゲツト・ヘツスレ Novel uses for pharmaceutical compounds
ZA889194B (en) * 1987-12-11 1989-08-30 Byk Gulden Lomberg Chemisch Fa Novel benzimidazole derivatives
AU3690289A (en) * 1988-05-25 1989-12-12 Byk Gulden Lomberg Chemische Fabrik Gmbh New fluoralkoxy compounds

Also Published As

Publication number Publication date
ZA914297B (en) 1992-03-25
PT98035A (en) 1992-03-31
IE912025A1 (en) 1992-01-01
IS3721A7 (en) 1991-12-21
OA09682A (en) 1993-05-15
CS189491A3 (en) 1992-04-15
SE9002206D0 (en) 1990-06-20
HUT62881A (en) 1993-06-28
AU649453B2 (en) 1994-05-26
ZA914296B (en) 1992-03-25
CA2083714A1 (en) 1991-12-21
YU104191A (en) 1994-01-20
EP0535081A1 (en) 1993-04-07
LT3977B (en) 1996-06-25
LTIP1712A (en) 1995-08-25
JPH05507713A (en) 1993-11-04
BG97200A (en) 1993-12-24
AP9100285A0 (en) 1991-07-31
WO1991019711A1 (en) 1991-12-26
AP215A (en) 1992-09-02
TW216418B (en) 1993-11-21
NO924775L (en) 1992-12-10
NZ238546A (en) 1994-03-25
LV10953A (en) 1995-12-20
AU8009791A (en) 1992-01-07
NO924775D0 (en) 1992-12-10
MA22199A1 (en) 1992-04-01
LTIP1713A (en) 1995-08-25
FI925766A0 (en) 1992-12-18
CN1058212A (en) 1992-01-29
IL98470A0 (en) 1992-07-15
HU9204033D0 (en) 1993-03-29
RO110493B1 (en) 1996-01-30
CZ279772B6 (en) 1995-06-14
FI925766A (en) 1992-12-18
LT3952B (en) 1996-05-27

Similar Documents

Publication Publication Date Title
TNSN91049A1 (en) SUBSTITUTED BENZIMIDAZOLES, PROCESSES FOR THEIR PREPARATION, AND THEIR PHARMACEUTICAL USE
TNSN91050A1 (en) DIALKOXY-PYRIDINYL-BENZIMIDAZOLE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, AND THEIR PHARMACEUTICAL USE
FR2439187A1 (en) SUBSTITUTED 1-PIPERAZINE-CARBOXAMIDES AND -CARBOTHIOAMIDES DERIVATIVES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN97110A1 (en) DERIVATIVES OF 2- (2-OXO-ETHYLIDENE) -IMIDAZOLIDINE-4-ONE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN97015A1 (en) NEW 19-NOR-PREGNENE DERIVATIVES.
TNSN96161A1 (en) NOVEL QUINOLEINE AND QUINAZOLINE DERIVATIVES FOR THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONS CONTAINING THEM.
BE903183A (en) NOVEL BENZONORBORNENE DERIVATIVES, PREPARATION METHODS THEREOF, AND MEDICINAL AND COSMETIC COMPOSITION CONTAINING THEM
BE904796A (en) NOVEL MORPHINANE AND MORPHINE DERIVATIVES, THEIR PREPARATION, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
TNSN88041A1 (en) NOVEL β-D-PHENYL THIOXYLOSIDES, THEIR PREPARATION PROCESS AND THEIR APPLICATION IN THERAPEUTICS
FR2404634A1 (en) THIAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS IN CONTAINER
FR2424259A1 (en) ACID ESTERS ((TRIFLUOROMETHYL-5 PYRIDYLOXY-2) -4 PHENOXY) -4 PENTENE-2 OIC USEFUL AS HERBICIDES
BE1000201A4 (en) ANTIBIOTIC COMPOUNDS, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2438654A1 (en) 2-METHYL-DIHYDROPYRIDINE COMPOUND, METHODS FOR OBTAINING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
KR870007118A (en) Optically pure compound and preparation method thereof
FR2455587A1 (en) BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF CARDIOVASCULAR CONDITIONS AND COMPOSITIONS CONTAINING THEM
TNSN95062A1 (en) NEW DIALKOXY-PYRIDINYLE-BENZIMIDAZOLE DERIVATIVES
FR2450817A1 (en) NOVEL OXIME-ETHERS COMPRISING A PYRIDINYL GROUP, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
KR920703082A (en) Prevention and treatment of fish diseases
FR2449401A1 (en) ADDITIVES FOR INGESTION AND / OR PHOTODEGRADABLE INSECTICIDES, INSECTICIDE COMPOSITIONS CONTAINING SUCH ADDITIVES AND METHODS FOR CONTROLLING INSECTS
BE1002181A3 (en) 3- (2-HALOALKYL) -1,4-OXATHIINS AND 2- (2-HALOALKYL) -1,4-DITHIINES, AS IS THE TREATMENT OF LEUKEMIA AND TUMORS WITH THESE SUBSTANCES.
FR2603587A1 (en) 2,3,4,5,6,7-HEXAHYDRO-2,7-METHANO-1,5-BENZOXAZONINE (OR -1,4-BENZOXAZONINE) DERIVATIVES, PROCESS FOR THEIR PREPARATION, MEDICAMENTS CONTAINING THEM AND INTERMEDIATE COMPOUNDS
EP0378825A3 (en) Alicyclic esters and their use as flavouring agents
TNSN92073A1 (en) QUATERNARY AMMONIUM DERIVATIVES OF (+) AND (-) 10- (1-AZABICYCLO [2,2,2] OCT-3-YL-METHYL) -10-H-PHENOTHIAZINE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR THEIR PREPARATION
PT84312B (en) PROCESS FOR THE PREPARATION OF NOVEL CYANO-2 BENZIMIDAZOLE DERIVATIVES OF FUNGICIDE COMPOSITIONS CONTAINING THEM AND THEIR ASSOCIATIONS WITH OTHER FUNGICIDES
OA09665A (en) Hydroquinone amino acid esters, process for their preparation and pharmaceutical or cosmetic compositions containing them